Health ❯ Cancer

Clinical Trials

Phase 1 Trials NIAGARA Trial Patient Stratification Translational Research Preclinical Studies Dana-Farber Cancer Institute Patient Treatment Randomized Trials Muscle Mass Disparities Oncology Phase II Trials Phase III Trials Drug Development Research Drug Efficacy

Ben Sasse Reports 76% Tumor Reduction on Experimental Pancreatic Cancer Drug

Early Phase 3 data show the RAS‑targeting pill extended median survival over chemotherapy.

Revolution Medicines’ Pancreatic Cancer Drug Lands ASCO Plenary After Phase 3 Survival Gain

Exercise Beats Ibuprofen in Early Trial for Chemo Brain

Theriva’s VCN-01 Extends Survival in Phase 2b Pancreatic Cancer Trial, Paving Way to Phase 3

UCSF Researchers Target Variant Bladder Cancer With CAR-T Therapy